The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

Secretary Xavier Becerra spoke to The Washington Post about falling trust in his department since the coronavirus pandemic.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

According to biographies posted to the department’s website Monday, Alicia Rouault is the department’s new associate deputy ...

AI is safe and trustworthy when deployed in healthcare. The plan emphasizes technical assistance for under-resourced ...

The FDA needs to strengthen guardrails to ensure its accelerated approval pathway is used appropriately, the HHS Office of ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price ...

The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...

The HHS Office of Inspector General (OIG), in connection with its enforcement responsibilities, must exclude a party from the ...

Steve Hernandez, Education’s CISO, and Brian Bordelon, Education’s deputy CIO, have moved to new agencies to take on similar roles.

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...